EconoTicker

BioNTech reported second-quarter earnings per share of –$1.60, missing the –$1.41 consensus as R&D and marketing costs for its cancer and flu vaccine programs weighed on the bottom line. However, revenue surged to $260.8 million, well above the $137.9 million forecast, driven by strong Comirnaty spike-vaccine sales and early orders for its next-generation flu shot. The outperformance lifted BioNTech’s market capitalization to about $26.8 billion. Management said the robust top-line momentum extends its cash runway into late 2026, enabling continued investment across oncology, infectious disease and mRNA pipeline candidates. Investors will watch upcoming trial data and partnership deals, which could further validate BioNTech’s platform and support its valuation amid rising competition in the vaccine space.

Berkshire Hathaway’s Class B shares reported earnings per share of $3.43 in the second quarter, falling short of the $4.99 consensus as declines in investment gains and lower underwriting profits weighed on net income. Nevertheless, revenue rose to $98.88 billion, beating the $92.61 billion forecast, driven by growth in insurance premiums, strong railroad and utility results, and robust industrial performance. The conglomerate’s market capitalization stands around $1.01 trillion, reflecting investor confidence in its diversified portfolio despite near-term earnings pressure. While the profit shortfall may temper sentiment, the revenue beat underscores the resilience of its core businesses. Investors will watch for capital-allocation moves—such as share repurchases and acquisitions—as Berkshire navigates slower market returns and seeks to bolster long-term value.

Nintendo’s ADR posted earnings per share of $0.5602, almost twice the $0.2944 consensus, while revenue surged to $3.89 billion, beating the $3.2 billion forecast. The strong performance was driven by blockbuster software releases and steady hardware sales of the Switch family, as well as digital content growth and in-game monetization. Mobile-game tie-ins also boosted top-line results, reflecting Nintendo’s expanding ecosystem. The company’s market capitalization stands at $108.97 billion, underscoring investor confidence in its intellectual-property pipeline. Management raised its full-year guidance for both profit and sales, citing a robust holiday launch schedule and ongoing cost discipline. The beat may support further stock gains, as Nintendo leverages its mascot franchises and new platforms to sustain momentum in the competitive gaming industry.

Chevron reported earnings per share of $1.77, narrowly beating the $1.75 consensus, while revenue fell to $44.82 billion, below the $45.6 billion forecast. Strong upstream margins—thanks to higher oil realizations and disciplined capital spending—offset weaker refining and chemicals unit results. Free cash flow rose, enabling Chevron to maintain its dividend and share-buyback program. With a market capitalization of about $312.8 billion, Chevron reaffirmed its full-year guidance, citing resilient project execution and cost controls amid commodity price volatility. Investors view the mixed beat as evidence of Chevron’s integrated model resilience, though softer downstream earnings highlight exposure to refining market cycles.

Exxon Mobil delivered better-than-expected second-quarter results, reporting earnings per share of $1.64 versus the $1.56 consensus, while revenue rose to $81.5 billion, ahead of $80.78 billion forecast. Strong upstream performance—driven by higher oil prices and resilient production—and robust chemicals division margins underpinned the beat. Downstream refining profits also rebounded as global fuel demand held up. Exxon’s market capitalization stands at roughly $454.1 billion, reinforcing its position among the world’s largest energy companies. Management raised its cash-flow guidance, citing tight supply dynamics and disciplined capital allocation. Investors may view the results as validation of Exxon’s integrated model, supporting the stock amid volatile commodity markets and evolving energy transitions.

Biogen delivered blockbuster results for its latest quarter, reporting earnings per share of $5.47, well above the $3.99 consensus. Revenue climbed to $2.6 billion, topping the $2.32 billion forecast, driven by strong demand for its flagship multiple sclerosis therapy, Aduhelm rollouts, and robust sales of spinraza for spinal muscular atrophy. Cost controls and higher-margin specialty products further boosted profitability. With a market capitalization near $18.96 billion, Biogen raised its full-year guidance, citing a healthy pipeline and accelerating launches across neurodegenerative and rare-disease franchises. Investors view the beat as validation of Biogen’s strategic focus on innovation, potentially supporting further stock gains amid a competitive biotech landscape.

S&P Global reported second-quarter earnings per share of $4.43, surpassing the $4.20 consensus, while revenue rose to $3.76 billion versus $3.66 billion expected. The outperformance was driven by strong demand for credit ratings, market intelligence and data subscriptions, as corporate and financial clients leaned into analytics amid market volatility. Adjusted operating margins expanded on disciplined cost management. With a market capitalization of roughly $171.7 billion, S&P Global reaffirmed its full-year outlook, citing robust pipeline activity and cross-sell opportunities in ESG and indices. Investors may view the results as validation of the company’s subscription-based model, supporting its stock in a search for stable growth amid economic uncertainty.

Shell’s American Depositary Receipt posted second-quarter earnings per ADR of $0.72, well below the $1.32 analysts expected, as refining margins narrowed and downstream margins softened. However, revenue climbed to $65.41 billion, topping the $62.03 billion forecast on stronger oil trading and chemicals sales. The mixed results reflect the challenges of volatile energy markets: higher commodity prices buoy sales but squeeze profit margins. Shell’s market capitalization stands near $213.7 billion, and management reaffirmed its full-year cash-flow targets, pointing to cost controls and planned asset sales for support. Investors may focus on Shell’s commitment to shareholder returns and its pivot toward lower-carbon businesses as it navigates industry headwinds.

Mastercard delivered quarterly earnings per share of $4.15, surpassing the $4.03 consensus, while revenue rose to $8.13 billion, ahead of the $7.93 billion forecast. The outperformance was driven by double-digit growth in cross-border volumes and strong card-not-present transactions as consumers and businesses increasingly embrace digital payments. Gross dollar volume climbed, supported by expanding merchant acceptance and robust travel-related spending. With a market capitalization of about $514.5 billion, Mastercard continues to benefit from its leading network position. Management reaffirmed its full-year outlook, pointing to ongoing product innovations and investment in cybersecurity as key growth levers. Investors are likely to view the results as validation of the company’s durable business model amid shifting payment trends.

Amazon reported earnings per share of $1.68, well above the $1.32 consensus, while revenue climbed to $167.7 billion versus $162.05 billion expected. Growth was driven by robust cloud-computing sales in AWS and strong e-commerce demand during Prime Day and back-to-school promotions. Advertising revenue also accelerated as brands ramped up spending on the platform. Operating margins improved on cost controls and higher-margin services, lifting net income and cash flow. Amazon’s market capitalization reached $2.37 trillion, reaffirming its status among the top three public companies. Management raised its full-year outlook for AWS growth, citing continued enterprise adoption and digital-commerce trends. Investors may view the results as validation of Amazon’s diversified model, supporting the stock amid macroeconomic and logistics-cost concerns.

Apple reported quarterly earnings per share of $1.57, beating the $1.42 consensus, and revenue of $94.04 billion versus $89 billion expected. Strong iPhone sales in emerging markets and robust growth in services—spanning the App Store, cloud subscriptions, and ad revenue—drove the outperformance. Mac and iPad sales were flat, while wearables maintained steady growth. Apple’s market capitalization reached approximately $3.16 trillion, cementing its lead as the world’s most valuable company. Management raised its guidance for services revenue, citing a growing installed base and higher average spending per user. Investors see the beat as confirmation of Apple’s diversified model, supporting the stock amid concerns over smartphone saturation and macroeconomic headwinds.

Qualcomm reported earnings per share of $2.77, beating the $2.71 consensus, while revenue rose to $10.37 billion against $10.33 billion expected. The beat was driven by robust chipset sales for 5G smartphones and growing automotive and IoT segments. Qualcomm’s Snapdragon platform saw strong adoption in both flagship and mid-range devices, and licensing revenues benefited from rising patent royalties. The company maintained its full-year guidance, citing resilient carrier rollouts and expanding design wins. With a market capitalization of $157.4 billion, Qualcomm remains a key play on mobile connectivity and next-generation wireless applications. Investors will watch for updates on 5G modem shipments and margin trends as Qualcomm faces increasing competition in China and from Aptiv in automotive chips.